IDH mutation detection in formalin-fixed paraffin-embedded gliomas using multiplex PCR and single-base extension

Brain Pathology

Volumn 22, Issue 5, 2012, Pages 619-624

  Perizzolo, Marco ^a   Winkfein, Bob ^a   Hui, Susan ^a   Krulicki, Wally ^a   Chan, Jennifer A ^a   Demetrick, Douglas J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

diagnostic; IDH1; IDH2; mutation detection; SNaPshot

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ALLELE; ARTICLE; CAPILLARY ELECTROPHORESIS; DNA EXTRACTION; GENE; GENE MUTATION; GENE SEQUENCE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOCITRATE DEHYDROGENASE 1 GENE; ISOCITRATE DEHYDROGENASE 2 GENE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FORMALDEHYDE; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; PARAFFIN; YOUNG ADULT;

EID: 84865496386     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00579.x     Document Type: Article

References (28)

1. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, et al, (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12: 1241-1252. (Pubitemid 36722604)
2. Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F, et al, (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224: 334-343.
3. Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F, (2010) Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J Neurooncol 99: 209-215.
4. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A, (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116: 597-602.
5. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al, (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851. (Pubitemid 30084326)
6. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J, (2010) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34: 1199-1204.
7. Capper D, Weissert S, Balss J, Habel A, Meyer J, Jager D, et al, (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20: 245-254.
8. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al, (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744.
9. Dang L, Jin S, Su SM, (2010) IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med 16: 387-397.
10. De Carli E, Wang X, Puget S, (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 2248; author reply 9.
11. Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, et al, (2009) IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology 73: 1792-1795.
12. Felsberg J, Wolter M, Seul H, Friedensdorf B, Goppert M, Sabel MC, Reifenberger G, (2010) Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. Acta Neuropathol 119: 501-507.
13. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, et al, (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol 118: 469-474.
14. Horbinski C, Kelly L, Nikiforov YE, Durso MB, Nikiforova MN, (2010) Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies. J Mol Diagn 12: 487-492.
15. Horbinski C, Kofler J, Kelly LM, Murdoch GH, Nikiforova MN, (2009) Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 68: 1319-1325.
16. Houillier C, Wang X, Kaloshi G, Mokhtari K, Guillevin R, Laffaire J, et al, (2010) IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology 75: 1560-1566.
17. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al, (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361: 1058-1066.
18. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al, (2011) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481: 380-384.
19. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al, (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
20. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, et al, (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28: 3061-3068.
21. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al, (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274. (Pubitemid 44571966)
22. Tefferi A, Jimma T, Sulai NH, Lasho TL, Finke CM, Knudson RA, et al, (2012) IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. Leukemia 26: 475-480.
23. Warburg O, Wind F, Negelein E, (1927) The metabolism of tumors in the body. J Gen Physiol 8: 519-530.
24. Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, et al, (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27: 5743-5750.
25. Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, et al, (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108: 19611-19616.
26. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al, (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19: 17-30.
27. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al, (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 765-773.
28. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al, (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324: 261-265.